1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts
(
- Contribution to journal › Article
- 2020
-
Mark
WFH Guidelines for the Management of Hemophilia, 3rd edition
(
- Contribution to journal › Article
- 2019
-
Mark
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
(
- Contribution to journal › Letter
- 2017
-
Mark
Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors
(
- Contribution to journal › Article
- 2016
-
Mark
Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors
(
- Contribution to journal › Article
- 2015
-
Mark
Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?
(
- Contribution to journal › Letter
- 2013
-
Mark
Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
(
- Contribution to journal › Article
-
Mark
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
(
- Contribution to journal › Article
-
Mark
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
(
- Contribution to journal › Article